Scleroderma heart disease is a major risk of death in systemic sclerosis (SSc). Mechanisms underlying myocardial damage are still unclear. We performed an extensive study of SSc patients with recent-onset symptoms for heart disease and examined the efficacy of immunosuppressive therapy.
Pieroni, M., De Santis, M., Zizzo, G., Bosello, S. L., Smaldone, C., Campioni, M., De Luca, G., Laria, A., Meduri, A., Bellocci, F., Bonomo, L., Crea, F., Ferraccioli, G., Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression, <<SEMINARS IN ARTHRITIS AND RHEUMATISM>>, 2014; 43 (4): 526-535. [doi:10.1016/j.semarthrit.2013.07.006] [http://hdl.handle.net/10807/60116]
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression
Pieroni, Maurizio;Bosello, Silvia Laura;Smaldone, Costantino;Campioni, Mara;Meduri, A;Bellocci, Fulvio;Bonomo, Lorenzo;Crea, Filippo;Ferraccioli, Gianfranco
2014
Abstract
Scleroderma heart disease is a major risk of death in systemic sclerosis (SSc). Mechanisms underlying myocardial damage are still unclear. We performed an extensive study of SSc patients with recent-onset symptoms for heart disease and examined the efficacy of immunosuppressive therapy.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
